Walleye Capital’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.7M | Buy |
18,822
+13,335
| +243% | +$10.4M | 0.06% | 183 |
|
|
2025
Q1 | $4.53M | Sell |
5,487
-1,880
| -26% | -$1.55M | 0.02% | 381 |
|
|
2024
Q4 | $5.69M | Sell |
7,367
-45,636
| -86% | -$35.2M | 0.01% | 399 |
|
|
2024
Q3 | $47M | Buy |
53,003
+34,164
| +181% | +$30.3M | 0.1% | 26 |
|
|
2024
Q2 | $17.1M | Buy |
18,839
+1,148
| +6% | +$1.04M | 0.03% | 133 |
|
|
2024
Q1 | $13.8M | Buy |
17,691
+4,599
| +35% | +$3.58M | 0.02% | 181 |
|
|
2023
Q4 | $7.63M | Buy |
+13,092
| New | +$7.63M | 0.02% | 253 |
|
|
2023
Q3 | – | Sell |
-348
| Closed | -$163K | – | 2662 |
|
|
2023
Q2 | $163K | Sell |
348
-86,350
| -100% | -$40.5M | ﹤0.01% | 1389 |
|
|
2023
Q1 | $29.8M | Buy |
+86,698
| New | +$29.8M | 0.45% | 11 |
|
|
2022
Q4 | – | Sell |
-12,601
| Closed | -$4.08M | – | 2403 |
|
|
2022
Q3 | $4.08M | Buy |
12,601
+7,075
| +128% | +$2.29M | 0.08% | 255 |
|
|
2022
Q2 | $1.79M | Buy |
+5,526
| New | +$1.79M | 0.05% | 387 |
|
|
2022
Q1 | – | Sell |
-22,167
| Closed | -$6.12M | – | 2374 |
|
|
2021
Q4 | $6.12M | Buy |
+22,167
| New | +$6.12M | 0.19% | 108 |
|
|
2021
Q3 | – | Sell |
-16,592
| Closed | -$3.81K | – | 1690 |
|
|
2021
Q2 | $3.81K | Sell |
16,592
-10,052
| -38% | -$2.31K | 0.13% | 111 |
|
|
2021
Q1 | $4.98K | Buy |
26,644
+7,547
| +40% | +$1.41K | 0.29% | 40 |
|
|
2020
Q4 | $3.22K | Buy |
+19,097
| New | +$3.22K | 0.22% | 66 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 706 |
|
|
2020
Q1 | – | Sell |
-960
| Closed | -$126K | – | 767 |
|
|
2019
Q4 | $126K | Buy |
960
+590
| +159% | +$77.4K | 0.01% | 447 |
|
|
2019
Q3 | $41K | Hold |
370
| – | – | ﹤0.01% | 368 |
|
|
2019
Q2 | $41K | Buy |
370
+170
| +85% | +$18.8K | ﹤0.01% | 336 |
|
|
2019
Q1 | $26K | Buy |
+200
| New | +$26K | ﹤0.01% | 279 |
|